Prescription Drugs » Cialis

cGMP-Dependent Protein Kinases and cGMP Phosphodiesterases in Nitric Oxide and cGMP Action.

admin — Thu, 26 Aug 2010 07:40:14 +0000

Authors: Francis SH, Busch JL, Corbin JD, Sibley D
To date, studies suggest that biological signaling by nitric oxide (NO) is primarily mediated by cGMP, which is synthesized by NO-activated guanylyl cyclases and broken down by cyclic nucleotide phosphodiesterases (PDEs). Effects of cGMP occur through three main groups of cellular targets: cGMP-dependent protein kinases (PKGs), cGMP-gated cation channels, and PDEs. cGMP binding activates PKG, which phosphorylates serines and threonines on many cellular proteins, frequently resulting in changes in activity or function, subcellular localization, or regulatory features. The proteins that are so modified by PKG commonly regulate calcium homeostasis, calcium sensitivity of cellular proteins, platelet activation and adhesion, smooth muscle c…

cGMP-Dependent Protein Kinases and cGMP Phosphodiesterases in Nitric Oxide and cGMP Action. is a post from: Prescription Drugs

Natural Wellness, Inc. Issues a Nationwide Voluntary Recall of Masxtreme Capsules, Marketed as a Dietary Supplement – 08/24/10

admin — Thu, 26 Aug 2010 07:40:14 +0000

Natural Wellness is announcing that it is conducting a nationwide voluntary recall of MasXtreme, Lot # 907043, UPC 094922300805. Laboratory analysis conducted by FDA has determined the product contains undeclared amounts of Aminotadalafil, an analog of tadalafil… (Source: Food and Drug Administration) MedWorm Message: Register for MedMatcha, MedWorm’s medical advertising network, and receive $5 free advertising. Natural Wellness, Inc. Issues a Nationwide Voluntary Recall of Masxtreme Capsules, Marketed as a Dietary Supplement – 08/24/10 is a post from: Prescription Drugs

Natural Wellness, Inc. Issues a Nationwide Voluntary Recall of Masxtreme Capsules, Marketed as a Dietary Supplement – 08/24/10 is a post from: Prescription Drugs

Sildenafil/tadalafil: First report of acute B-lymphoblastic leukaemia secondary to bone marrow toxicity: case report

admin — Mon, 16 Aug 2010 13:00:12 +0000

(Source: Reactions) MedWorm Message: Register for MedMatcha, MedWorm’s medical advertising network, and receive $5 free advertising. Sildenafil/tadalafil: First report of acute B-lymphoblastic leukaemia secondary to bone marrow toxicity: case report is a post from: Prescription Drugs

Sildenafil/tadalafil: First report of acute B-lymphoblastic leukaemia secondary to bone marrow toxicity: case report is a post from: Prescription Drugs

Revivexxx Extra Strength: Recall – Undeclared Drug Ingredient

admin — Sun, 15 Aug 2010 07:40:12 +0000

Audience: Consumer ISSUE: FDA lab analysis of Revivexxx Extra Strength was found to contain undeclared tadalafil. Tadalafil is an FDA-approved drug for the treatment of male Erectile Dysfunction (ED), making Revivexxx Extra Strength an unapproved… (Source: Drugs.com – FDA MedWatch Alerts) Revivexxx Extra Strength: Recall – Undeclared Drug Ingredient is a post from: Prescription Drugs

Revivexxx Extra Strength: Recall – Undeclared Drug Ingredient is a post from: Prescription Drugs

Revivexxx Extra Strength: Recall – Undeclared Drug Ingredient

admin — Sun, 15 Aug 2010 07:40:12 +0000

Product marketed as a dietary supplement sexual enhancer for men contains undeclared tadalafil, which may interact with nitrates found in some prescription drugs such as nitroglycerin and may lower blood pressure to dangerous levels. (Source: FDA MedWatch) Revivexxx Extra Strength: Recall – Undeclared Drug Ingredient is a post from: Prescription Drugs

Revivexxx Extra Strength: Recall – Undeclared Drug Ingredient is a post from: Prescription Drugs

EZVille, Ltd. Issues A Voluntary Nationwide Recall Of Revivexxx® Extra Strength Found To Contain An Undeclared Drug Ingredient

admin — Sun, 15 Aug 2010 07:40:12 +0000

EZVille, Ltd. of Ronkonkoma, NY, has been informed by the US Food and Drug Administration (FDA) that FDA lab analysis of Revivexxx® Extra Strength distributed by the company was found to contain undeclared tadalafil. Tadalafil is an FDA-approved drug for the treatment of male Erectile Dysfunction (ED), making Revivexxx® Extra Strength an unapproved drug. FDA advises that this poses a threat to consumers because tadalafil may interact with nitrates found in some prescription drugs such as nitroglycerin and may lower blood pressure to dangerous levels… (Source: Health News from Medical News Today)

EZVille, Ltd. Issues A Voluntary Nationwide Recall Of Revivexxx® Extra Strength Found To Contain An Undeclared Drug Ingredient is a post from: Prescription Drugs

Phosphodiesterase-5 inhibitor tadalafil acts on endothelial progenitor cells by CXCR4 signalling.

admin — Sun, 15 Aug 2010 07:40:12 +0000

Authors: Foresta C, De Toni L, Magagna S, Galan A, Garolla A
It has been proposed that endothelial progenitor cells (EPC), originating from the bone marrow contribute to neo-angiogenesis in vivo by forming endothelial cells. Once released in the bloodstream, EPC home at the site of vascular damage where they participate in endothelium regeneration. In this process CXCR4 plays a key role. Recently we demonstrated that a prolonged therapy with phosphodiesterase-5 (PDE5) inhibitors does improve endothelial function and increases circulating EPC, suggesting a role of PDE5 in EPC physiology. Here we tested the expression of PDE5 and CXCR4 on cultured, circulating, and bone marrow resident EPC, and we studied the effect in vivo and in vitro of PDE5 inhibition after administration of a PDE5 i…

MedWorm Message: Register for MedMatcha, MedWorm’s medical advertising network, and receive $5 free advertising.

Phosphodiesterase-5 inhibitor tadalafil acts on endothelial progenitor cells by CXCR4 signalling. is a post from: Prescription Drugs

EZVille, Ltd. Issues a Voluntary Nationwide Recall of Revivexxx® Extra Strength Found to Contain an Undeclared Drug Ingredient

admin — Tue, 10 Aug 2010 10:00:17 +0000

EZVille, Ltd. of Ronkonkoma, NY, has been informed by the US Food and Drug Administration (FDA) that FDA lab analysis of Revivexxx® Extra Strength distributed by the company was found to contain undeclared tadalafil. Tadalafil is an FDA-approved drug for the treatment of male Erectile Dysfunction (ED), making Revivexxx® Extra Strength an unapproved drug. (Source: Food and Drug Administration) MedWorm Message: Register for MedMatcha, MedWorm’s medical advertising network, and receive $5 free advertising. EZVille, Ltd. Issues a Voluntary Nationwide Recall of Revivexxx® Extra Strength Found to Contain an Undeclared Drug Ingredient ...

EZVille, Ltd. Issues a Voluntary Nationwide Recall of Revivexxx® Extra Strength Found to Contain an Undeclared Drug Ingredient is a post from: Prescription Drugs

Tadalafil-Induced Transient Global Amnesia [LETTERS TO THE EDITOR]

admin — Sat, 07 Aug 2010 04:07:34 +0000

(Source: J Neuropsychiatry Clin Neurosci) Tadalafil-Induced Transient Global Amnesia [LETTERS TO THE EDITOR] is a post from: Prescription Drugs

Tadalafil-Induced Transient Global Amnesia [LETTERS TO THE EDITOR] is a post from: Prescription Drugs

Hypogonadal Men Nonresponders to the PDE5 Inhibitor Tadalafil Benefit from Normalization of Testosterone Levels with a 1% Hydroalcoholic Testosterone Gel in the Treatment of Erectile Dysfunction (TADTEST Study)

admin — Sat, 07 Aug 2010 04:07:34 +0000

Conclusions. The maximal beneficial effects of OAD dosing with 10 mg tadalafil may occur only after as many as 12 weeks. Furthermore, addition of T to this PDE5-I regimen is beneficial, but only in hypogonadal men with baseline T levels [le]3 ng/mL. Buvat J, Montorsi F, Maggi M, Porst H, Kaipia A, Colson MH, Cuzin B, Moncada I, Martin-Morales A, Yassin A, Meuleman E, Eardley I, Dean JD, and Shabsigh R. Hypogonadal men nonresponders to the PDE5 inhibitor tadalafil benefit from normalization of testosterone levels with a 1% hydroalcoholic testosterone gel in the treatment of erectile dysfunction (TADTEST study). J Sex Med **;**:**[ndash]**. (Source: The Journal of Sexual Medicine)

MedWorm Message: Register for MedMatcha, MedWorm’s medical advertising network, and receive $5 free advertising.

Hypogonadal Men Nonresponders to the PDE5 Inhibitor Tadalafil Benefit from Normalization of Testosterone Levels with a 1% Hydroalcoholic Testosterone Gel in the Treatment of Erectile Dysfunction (TADTEST Study) is a post from: Prescription Drugs